Prostate Cancer

Is vasectomy linked to risk of prostate cancer?

Is vasectomy linked to risk of prostate cancer?

By

Vasectomy can continue to be a safe method of contraception in men.

Risk of Alzheimer dementia after androgen deprivation therapy

Risk of Alzheimer dementia after androgen deprivation therapy

By

A recent cohort study evaluated the risk of developing Alzheimer dementia after ADT in 16,888 men with prostate cancer, 14.2% of whom were treated with ADT.

Diagnostic factors help patients avoid confirmatory prostate biopsy

Diagnostic factors help patients avoid confirmatory prostate biopsy

The analysis of diagnostic characteristics may predict the result of a confirmatory biopsy.

Prostate cancer treatment linked to Alzheimer's risk

Prostate cancer treatment linked to Alzheimer's risk

By

Patients treated with androgen deprivation therapy had a 1.88-times increased rate of developing Alzheimer's disease.

Active surveillance of low-risk prostate cancer patients may not be efficient

Active surveillance of low-risk prostate cancer patients may not be efficient

New research suggests that men with low-risk prostate cancer who undergo choose watchful waiting may not receive timely treatment when compared to those undergoing active treatment.

Reduction in number of men screened for and diagnosed with prostate cancer

Reduction in number of men screened for and diagnosed with prostate cancer

In the United States, the rate of prostate cancer screening is down, and the number of men diagnosed with the disease has also dropped.

Active surveillance 
encouraged for prostate cancer screening

Active surveillance 
encouraged for prostate cancer screening

By

Men should regularly be screened for prostate cancer, the leading cause of cancer death for men in the United States.

More radiation does not increase survival in low-risk prostate cancer

More radiation does not increase survival in low-risk prostate cancer

Higher doses of radiation does not increase survival rates in low-risk prostate cancer.

Targeted PSA screening prevents overdiagnosis, overtreatment

Targeted PSA screening prevents overdiagnosis, overtreatment

By

More targeted efforts needed for prostate-specific antigen screening.

Radiation, hormone therapy for prostate cancer

Radiation, hormone therapy for prostate cancer

By

Combination radiation and hormone therapy is more effective than hormone therapy alone for the treatment of prostate cancer.

Primary care after PCa

Primary care after PCa

PCPs should encourage physical activity, smoking cessation, and a healthy diet for PCa survivors.

New imaging methods better for prostate CA detection

New imaging methods better for prostate CA detection

Multiparametric magnetic resonance imaging reported high accuracy in diagnosing low-risk prostate cancers.

Prostate cancer care measures vary by region

Prostate cancer care measures vary by region

Low adherence rates for prostate cancer care may be target for future quality improvements.

Prostatectomy cuts mortality in early prostate CA

Prostatectomy cuts mortality in early prostate CA

Risk of long-term mortality is lower compared with watchful waiting.

Melatonin linked to lower prostate CA risk

Melatonin linked to lower prostate CA risk

Risk for advanced prostate cancer was 75% lower in men with high levels of 6-sulfatoxymelatonin -- a measure of melatonin breakdown in urine.

Baseline inflammation lowers prostate cancer risk on repeat biopsy

Baseline inflammation lowers prostate cancer risk on repeat biopsy

Even after adjustment, acute, chronic inflammation linked to lower PCa risk at two-year repeat biopsy.

Prostate biopsy causes anxiety even when negative

Prostate biopsy causes anxiety even when negative

Potential psychological harm associated with biopsy even in absence of cancer diagnosis

Coffee protective against prostate CA recurrence

Coffee protective against prostate CA recurrence

Drinking coffee may lower the risk for prostate cancer recurrence and disease progression.

Men don't rely on prostate-screen decision aids

Men don't rely on prostate-screen decision aids

By

Aids help men make more informed choices regarding PSA screening, but did not affect actual screening rates.

Soy not protective against prostate CA recurrence

Soy not protective against prostate CA recurrence

Men consuming a soy supplement on a daily basis saw no reduction in their chances of prostate cancer recurrence.

Consuming more vegetable fat may cut prostate cancer mortality

Consuming more vegetable fat may cut prostate cancer mortality

Replacing carbohydrates and animal fat with vegetable fat may reduce prostate cancer mortality.

FDA approves Xofigo for advanced prostate cancer

FDA approves Xofigo for advanced prostate cancer

By

Xofigo has been approved three months ahead of schedule to treat men with metastatic castration-resistant prostate cancer.

Exercise cuts prostate cancer risk in whites

Exercise cuts prostate cancer risk in whites

Regular, moderate exercise was associated with decreased prostate cancer risk in white, but not black, men.

FDA approves Zytiga for advanced prostate cancer

FDA approves Zytiga for advanced prostate cancer

The FDA has expanded the indication for abiraterone acetate to include treating late-stage castration-resistant prostate cancer before the administration of chemotherapy.

Examining the prostate of an obese man

Examining the prostate of an obese man

Excess fat around the gluteal region can make performing digital rectal exams in obese patients difficult. How can this challenge be overcome?

FDA approves prostate cancer imaging agent

FDA approves prostate cancer imaging agent

Choline C 11 Injection, a PET scan imaging agent, is now available for men with elevated PSA levels after earlier treatment for prostate cancer.

Cancer survivors uneasy with primary care follow-up

Cancer survivors uneasy with primary care follow-up

Lack of cancer expertise, continuity of care cited as barriers to receiving follow-up cancer care from primary care providers.

FDA approves new test for prostate cancer

FDA approves new test for prostate cancer

The Prostate Health Index is a non-invasive blood test that is 2.5-times more specific in detecting prostate cancer than prostate-specific antigen in patients with PSA values in the 4-10 ng/mL range.

USPSTF recommends against PSA-based screening

Based on the evidence, the U.S. Preventive Services Task Force gave a grade D recommendation against PSA-based screening for men in the general U.S. population, regardless of age.

Prostate cancer: To screen or not to screen?

By

Only 50% of clinicians surveyed agree with U.S. Preventive Services Task Force recommendations not to perform routine PSA screening.

Sign Up for Free e-newsletters